Introduction
============

It is well known that certain foods may have the potential to prevent diseases \[[@B1-molecules-13-01189],[@B2-molecules-13-01189]\]. For instance, the Mediterranean diet is helpful to lowering the risks of coronary heart disease, cancer and cognitive impairment \[[@B3-molecules-13-01189],[@B4-molecules-13-01189],[@B5-molecules-13-01189]\]. Consumption of green tea is beneficial for preventing cancer and Alzheimer's disease (AD) \[[@B6-molecules-13-01189],[@B7-molecules-13-01189],[@B8-molecules-13-01189]\]. Recently, Villegas and co-workers reported that adherence to vegetables (including cruciferous vegetables, green leafy vegetables, yellow vegetables, allium vegetables, tomatoes and others) and legumes (including soybean, peanut, *etc.*) is inversely associated with the risk of type 2 diabetes (T2D) in a large Chinese population \[[@B9-molecules-13-01189],[@B10-molecules-13-01189]\]. However, the health benefits of these plants have not been fully explained, which stimulated our interest to address this issue further. Considering the fact that some foods have been recognized as natural medicines, in particular some vegetables and legumes have been used as traditional medicines in China for many years, we speculated that it is highly possible to pinpoint food component functions by searching medicinal databases, especially those containing traditional Chinese medicines.

![TCMD-documented vegetable and legume components with aldose reductase inhibitory or hypoplycemic activity.](molecules-13-01189-g001){#molecules-13-01189-f001}

Results and Discussion
======================

Primarily, we searched the Traditional Chinese Medicine Database (TCMD), which documents \~10,000 components extracted from \~4,600 traditional medicinal agents \[[@B11-molecules-13-01189]\]. Hundreds of components were identified from vegetables and legumes that are recorded in the TCMD. According to the pharmacological activity annotations, we found that some components ([Figure 1](#molecules-13-01189-f001){ref-type="fig"}) are directly associated with prevention and/or treatment of T2D, because of their aldose reductase inhibitory or hypoplycemic activity.

Besides, the functions of many other vegetable and legume components (*e.g.*, antiatherosclerotic, antihypertensive, antilipemic, antithrombotic, lipase inhibitory, lipid peroxidation inhibitory, lipoxygenase inhibitory and platelet aggregation inhibitory) are also associated with ameliorating T2D ([Table 1](#molecules-13-01189-t001){ref-type="table"}) \[[@B12-molecules-13-01189],[@B13-molecules-13-01189],[@B14-molecules-13-01189],[@B15-molecules-13-01189],[@B16-molecules-13-01189]\].

molecules-13-01189-t001_Table 1

###### 

TCMD-documented vegetable and legume functional components associated with ameliorating type 2 diabetes.

  -----------------------------------------------------------------------------------------------------------------------
  Compound                          Activity                            Source
  --------------------------------- ----------------------------------- -------------------------------------------------
  Aframodial                        Antilipemic                         Zingiber (*Zingiber officinale Rosc.*)

  Agavasaponin C                    Platelet aggregation inhibitory     Garlic (*Allium sativum L.*)

  Allicin                           Antihypertensive;                   Shallot (*Allium fislulosum L.*);

  Antithrombotic                    Garlic (*Allium sativum L.*)        

  Alliin                            Antithrombotic;                     Onion (*Allium cepa L.*);

  Platelet aggregation inhibitory   Garlic (*Allium sativum L.*)        

  Bergapten                         Antihypertensive                    Tomato (*Lycopersicon esculentum Miller*)

  beta-Sitosterol                   Antilipemic                         Black soybean (*Glycine max (L.) Merr.*)

  Camphene                          Antilipemic                         Zingiber (*Zingiber officinale Rosc.*);\
                                                                        Mint (*Mentha haplocalyx Briq.*)

  Daidzein                          Lipase inhibitory                   Black soybean (*Glycine max (L.) Merr.*)

  Ferulic acid                      Platelet aggregation inhibitory     Onion (*Allium cepa L.*)

  Genistein                         Lipase inhibitory                   Black soybean (*Glycine max (L.) Merr.*)

  Glycitein                         Lipoxygenase inhibitory             Black soybean (*Glycine max (L.) Merr.*)

  Isoeruboside B                    Platelet aggregation inhibitory     Garlic (*Allium sativum L.*)

  Isorhamnetin                      Antilipemic;\                       Cress (*Oenanthe javanica (B1.)DC.*)
                                    Platelet aggregation inhibitory     

  Kaempferol                        Δ-5-lipoxygenase inhibitory         Wild pea (*Vicia amoena Fisch. ex DC.*)

  Leucocyanidin                     Platelet aggregation inhibitory     Groundnut (*Arachis hypogaea L.*)

  Lycopene                          Antiatherosclerotic                 Tomato (*Lycopersicon esculentum Miller*);\
                                                                        Bitter gourd (*Momordica charantia L.*)

  Methyl allyl trisulfide           Platelet aggregation inhibitory     Garlic (*Allium sativum L.*)

  Myristicin                        Platelet aggregation inhibitory     Wild celery (*Apium graveolens L.*)

  p-Coumaric acid                   Antilipemic                         Potato (*Solanum tuberosum L.*)

  Proto-iso-eruboside B             Antithrombotic                      Garlic (*Allium sativum L.*)

  Rosmarinic acid                   Antithrombotic;\                    Mint (*Mentha haplocalyx Briq.*)
                                    Platelet aggregation inhibitory     

  6-Shogaol                         Antihypertensive;\                  Zingiber (*Zingiber officinale Rosc.*)
                                    Platelet aggregation inhibitory     

  Solasonine                        Platelet aggregation inhibitory     Capsicum (*Capsicum annuum L.*);\
                                                                        Eggplant (*Solanum melongena L.*)

  Soyasaponin A1                    Antilipemic;\                       Black soybean (*Glycine max (L.) Merr.*)
                                    Antithrombotic                      

  Soyasaponin A2                    Antilipemic                         Black soybean (*Glycine max (L.) Merr.*)

  Soyasaponin A3                    Lipoxygenase inhibitory             Black soybean (*Glycine max (L.) Merr.*)

  Soyasaponin A4                    Lipoxygenase inhibitory             Black soybean (*Glycine max (L.) Merr.*)

  Soyasaponin A5                    Lipoxygenase inhibitory             Black soybean (*Glycine max (L.) Merr.*)

  Soyasaponin A6                    Lipoxygenase inhibitory             Black soybean (*Glycine max (L.) Merr.*)

  Soyasaponin V                     Lipoxygenase inhibitory             Black soybean (*Glycine max (L.) Merr.*);\
                                                                        White kidney bean (*Phaseolus vulgaris L.*)

  Stigmasterol                      Antilipemic                         Black soybean (*Glycine max (L.) Merr.*);\
                                                                        Purple haricot (*Lablab purpureus (L.)Sweet*);\
                                                                        Groundnut (*Arachis hypogaea L.*);\
                                                                        White kidney bean (*Phaseolus vulgaris L.*)

  Tomatine                          Antihypertensive                    Tomato (*Lycopersicon esculentum Miller*)

  2-Vinyl-4H-1,3-dithiin            Platelet aggregation inhibitory;\   Garlic (*Allium sativum L.*)
                                    Antithrombotic;\                    
                                    5-lipoxygenase inhibitory           
  -----------------------------------------------------------------------------------------------------------------------

Furthermore, through comparing the structures of these components with those recorded in the Comprehensive Medicinal Chemistry (CMC) database (which records \~8,000 clinically used drugs) \[[@B17-molecules-13-01189]\] and the MDL Drug Data Report (MDDR) database (which collects \~145,000 drug candidates) \[[@B18-molecules-13-01189]\], we found that some of these agents have been recognized by modern Western medicine ([Table 2](#molecules-13-01189-t002){ref-type="table"}). Although some activities annotated in CMC and MDDR are not the same as displayed in TCMD, they are also associated with combating T2D. Taken together, the present analysis clearly indicates that vegetables and legumes indeed contain many antidiabetic components, which provide new clues to understanding the beneficial effects of vegetable and legume consumption on the risk of T2D \[[@B9-molecules-13-01189],[@B10-molecules-13-01189]\].

molecules-13-01189-t002_Table 2

###### 

CMC- and MDDR-documented vegetable and legume functional components associated with ameliorating type 2 diabetes.

  ------------------------------------------------------------------------------
  Compound                              Activity
  ------------------------------------- ----------------------------------------
  Allicin                               Hypolipidemic (CMC/MDDR);\
                                        Hypocholesterolemic (CMC);\
                                        Platelet aggregation inhibitory (MDDR)

  6-Shogaol                             Cyclooxygenase inhibitory (MDDR);\
                                        Lipoxygenase inhibitory (MDDR)

  beta-Sitosterinum (beta-Sitosterol)   Hypolipidemic (CMC)

  Stigmasterin (Stigmasterol)           Antiatherosclerotic (CMC)
  ------------------------------------------------------------------------------

Conclusions
===========

Since only a small part of natural medicinal components have been documented in medicinal databases, the presently identified vegetable and legume functional components are only the tip of the iceberg. It is expected that with the progress of medicinal chemistry and pharmacology, more and more antidiabetic agents will be identified from foods. In fact, in a very recent study, it was reported that some triterpenoids derived from bitter melon are promising antidiabetic agents \[[@B19-molecules-13-01189]\].

In nutrition studies, it is always a challenge to pinpoint the functions of food components to elucidate the epidemiological discoveries. The present study indicates that it is possible to explain (although partially) the health benefits of foods from the activities annotated in medicinal databases, which is of great significance to the study of food science and technology and even drug discovery.
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